RDY
Dr. Reddy's Laboratories Ltd.

599
Mkt Cap
$11.67B
Volume
1.57M
52W High
$16.17
52W Low
$12.26
PE Ratio
17.16
RDY Fundamentals
Price
$14.02
Prev Close
$14.09
Open
$14.09
50D MA
$14.01
Beta
0.39
Avg. Volume
1.01M
EPS (Annual)
$0.8029
P/B
2.90
Rev/Employee
$138,447.28
Loading...
Loading...
News
all
press releases
Zacks Industry Outlook Highlights Sandoz, Teva Pharmaceuticals and Dr. Reddy's
Sandoz, Teva and Dr. Reddy's emerge as standouts as generic drugmakers lean on biosimilars, complex generics and tighter cost controls.
Zacks·4d ago
News Placeholder
More News
News Placeholder
3 Generic Drug Stocks to Watch Amid Changing U.S. Landscape
Generic drugmakers face U.S. pricing pressure, but TEVA, SDZNY and RDY gain momentum through complex generics and biosimilars.
Zacks·5d ago
News Placeholder
Virtus Advisers LLC Purchases Shares of 118,945 Dr. Reddy's Laboratories Ltd $RDY
Virtus Advisers LLC acquired a new position in shares of Dr. Reddy's Laboratories Ltd (NYSE:RDY - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with...
MarketBeat·11d ago
News Placeholder
Aurigene Oncology Limited Announces Encouraging Initial Data From 1st Two Cohorts of Phase 1 Study of AUR112, an Oral Small Molecule Inhibitor of MALT1, in Relapsed/Refractory Lymphoid Malignancies
Aurigene Oncology Limited, a clinical-stage biopharmaceutical company developing novel therapies in oncology, today announced initial clinical results from 1st two cohorts of its ongoing Phase 1...
Business Wire·11d ago
News Placeholder
Grantham Mayo Van Otterloo & Co. LLC Trims Stock Position in Dr. Reddy's Laboratories Ltd $RDY
Grantham Mayo Van Otterloo & Co. LLC lessened its stake in Dr. Reddy's Laboratories Ltd (NYSE:RDY - Free Report) by 59.0% in the 2nd quarter, according to the company in its most recent filing with...
MarketBeat·12d ago
News Placeholder
West Family Investments Inc. Buys 23,966 Shares of Dr. Reddy's Laboratories Ltd $RDY
West Family Investments Inc. lifted its stake in Dr. Reddy's Laboratories Ltd (NYSE:RDY - Free Report) by 37.1% during the 2nd quarter, according to its most recent disclosure with the Securities...
MarketBeat·13d ago
News Placeholder
JPMorgan Chase & Co. Grows Stock Holdings in Dr. Reddy's Laboratories Ltd $RDY
JPMorgan Chase & Co. increased its position in Dr. Reddy's Laboratories Ltd (NYSE:RDY - Free Report) by 157.7% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned...
MarketBeat·14d ago
News Placeholder
Bausch (BHC) Down 5.5% Since Last Earnings Report: Can It Rebound?
Bausch (BHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·15d ago
News Placeholder
Thornburg Investment Management Inc. Sells 42,299 Shares of Dr. Reddy's Laboratories Ltd $RDY
Thornburg Investment Management Inc. reduced its holdings in Dr. Reddy's Laboratories Ltd (NYSE:RDY - Free Report) by 59.6% during the 2nd quarter, according to the company in its most recent 13F...
MarketBeat·15d ago
News Placeholder
Quadrant Capital Group LLC Has $4 Million Position in Dr. Reddy's Laboratories Ltd $RDY
Quadrant Capital Group LLC raised its stake in Dr. Reddy's Laboratories Ltd (NYSE:RDY - Free Report) by 71.6% in the 2nd quarter, according to its most recent 13F filing with the Securities and...
MarketBeat·15d ago

Latest RDY News

View

Advertisement|Remove ads.

Advertisement|Remove ads.